Norms of vagal nerve activity, indexed by Heart Rate Variability, in cancer patients

Cancer Epidemiology

Volumn 37, Issue 5, 2013, Pages 737-741

  De Couck, M ^a   Gidron, Y ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Age; Cancer patients; Gender; Heart Rate Variability; Neuromodulation; Stage; Vagal nerve activity

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART RATE VARIABILITY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; VAGUS NERVE;

AGE; CANCER PATIENTS; GENDER; HEART RATE VARIABILITY; NEUROMODULATION; STAGE; VAGAL NERVE ACTIVITY;

AGE FACTORS; AGED; CASE-CONTROL STUDIES; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; RETROSPECTIVE STUDIES; SEX FACTORS; VAGUS NERVE;

EID: 84884146969     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.04.016     Document Type: Article

References (48)

1. Kuo T.B., Lai C.J., Huang Y.T., Yang C.C. Regression analysis between heart rate variability and baroreflex-related vagus nerve activity in rats. J Cardiovasc Electrophysiol 2005, 16(8):864-869.
2. Tsuji H., Larson M.G., Venditti F.J., Manders E.S., Evans J.C., Feldman C.L., et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996, 94(11):2850-2855.
3. Kiviniemi A.M., Tulppo M.P., Wichterle D., Hautala A.J., Tiinanen S., Seppänen T., et al. Novel spectral indexes of heart rate variability as predictors of sudden and non-sudden cardiac death after an acute myocardial infarction. Ann Med 2007, 39(1):54-62.
4. Oikawa K., Ishihara R., Maeda T., Yamaguchi K., Koike A., Kawaguchi H., et al. Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol 2009, 131(3):370-377.
5. Ong M.E., Padmanabhan P., Chan Y.H., Lin Z., Overton J., Ward K.R., et al. An observational, prospective study exploring the use of heart rate variability as a predictor of clinical outcomes in pre-hospital ambulance patients. Resuscitation 2008, 78(3):289-297.
6. Gidron Y., Perry H., Glennie M. The vagus may inform the brain about sub-clinical tumors and modulate them: an hypothesis. Lancet Oncol 2005, 6:245-248.
7. De Couck M., Mravec B., Gidron Y. You may need the vagus nerve to understand pathophysiology and to treat diseases. Clin Sci (Lond) 2012, 122:323-328.
8. Valko M., Izakovic M., Mazur M., Rhodes C.J., Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004, 266:37-56.
9. Faux S.P., Tai T., Thorne D., Xu Y., Breheny D., Gaca M. The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers 2009, 14:90-96.
10. Maki A., Kono H., Gupta M., Asakawa M., Suzuki T., Matsuda M., et al. Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Ann Surg Oncol 2007, 14(3):1182-1190.
11. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
12. Voronov E., Shouval D.S., Krelin Y., Benharroch D., Iwakura Y., Dinarellon C.A., et al. IL-1 is required for tumour invasiveness and angiogenesis. Proc Natl Acad Sci U S A 2003, 100:2645-2650.
13. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
14. Entschladen F., Drell T.L., Lang K., Joseph J., Zaenker K.S. Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol 2004, 5(4):254-258.
15. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
16. Ek M., Kurosawa M., Lundeberg T., Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci 1998, 18:9471-9479.
17. Pavithran P., Nandeesha H., Sathiyapriya V., Bobby Z., Madanmohan T. Shortterm heart variability and oxidative stress in newly diagnosed essential hypertension. Clin Exp Hypertens 2008, 30(7):486-496.
18. Vlcek M., Radikova Z., Penesova A., Kvetnansky R., Imrich R. Heart rate variability and catecholamines during hypoglycemia and orthostasis. Auton Neurosci 2008, 143(1-2):53-57.
19. Mravec B., Gidron Y., Kukanova B., Bizik J., Kiss A., Hulin I. Neural-endocrineimmune complex in the central modulation of tumorigenesis: facts, assumptions, and hypotheses. J Neuroimmunol 2006, 180(1-2):104-116.
20. Hoffmann J., Grimm W., Menz V., Wied M., Sprenger A., Arnold R., et al. Prognostic value of heart rate variability analysis in patients with carcinoid syndrome. Digestion 2001, 63(1):35-42.
21. Fadul N., Strasser F., Palmer L.J., Yusuf S.W., Guo Y., Li Z., et al. The association between autonomic dysfunction and survival in male patients with advanced cancer: a preliminary report. J Pain Symptom Manage 2010, 39(2):283-290.
22. Chiang J.K., Koo M., Kuo T.B., Fu C.H. Association between cardiovascular autonomic functions and time to death in patients with terminal hepatocellular carcinoma. J Pain Symptom Manage 2001, 39:673-679.
23. Kim do H., Kim J.A., Choi Y.S., Kim S.H., Lee J.Y., Kim Y.E. Heart rate variability and length of survival in hospice cancer patients. J Korean Med Sci 2010, 25(8):1140-1145.
24. Mouton C., Ronson A., Razavi D., Delhaye F., Kupper N., Paesmans M., et al. The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer. Auton Neurosci 2012, 26:96-99.
25. De Couck M., van Brummelen D., Schallier D., De Grève J., Gidron Y. The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients. Oncol Rep 2013, accepted for publication.
26. Erin N., Boyer P.J., Bonneau R.H., Clawson G.A., Welch D.R. Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart. Anticancer Res 2004, 24:1003-1009.
27. Erin N., Akdas Barkan G., Harms J.F., Clawson G.A. Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level. Regul Peptides 2008, 151(1-3):35-42.
28. Erin N., Duymuş O., Oztürk S., Demir N. Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasis. Regul Peptides 2012.
29. Thong T. Predicting imminent episodes of ventricular tachyarrhythmia-retrospective analysis of short R-R records from ICD. Conf Proc IEEE Eng Med Biol Soc 2008, 5664-5667.
30. Nussinovitch U., Elishkevitz K.P., Katz K., Nussinovitch M., Segev S., Volovitz B., et al. Reliability of ultra-short ECG indices for heart rate variability. Ann Noninvasive Electrocardiol 2011, 16:117-122.
31. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996, 93:1043-1065.
32. Dekker J.M., Schouten E.G., Klootwojk P., Pool J., Swenne C.A., Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. Am J Epidemiol 1997, 145(10):899-908.
33. Walsh D., Nelson K.A. Autonomic nervous system dysfunction in advanced cancer. Support Care Cancer 2002, 10:523-528.
34. Bruera E., Chadwick S., Fox R., Hanson J., MacDonald N. Study of cardiovascular autonomic insufficiency in advanced cancer patients. Cancer Treat Rep 1986, 70:1383-1387.
35. Nunan D., Sandercock G.R., Brodie D.A. A quantitative systematic review of normal values for short-term heart rate variability in healthy adults. Pacing Clin Electrophysiol 2010, 33(11):1407-1417.
36. Tjeerdsma G., Meinardi M.T., van Der Graaf W.T., van Den Berg M.P., Mulder N.H., Crijns H.J., et al. Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables. Heart 1999, 81(4):419-423.
37. Bruera E., Catz Z., Hooper R., et al. Chronic nausea and anorexia in advanced cancer patients: a possible role for autonomic dysfunction. J Pain Symptom Manage 1987, 2:19-21.
38. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
39. Crimmins E.M., Johnston M., Hayward M., Seeman T. Age differences in allostatic load: an index of physiological dysregulation. Exp Gerontol 2003, 38:731-734.
40. Ramaekers D., Ector H., Aubert A.E., Rubens A., Van de Werf F. Heart rate variability and heart rate in healthy volunteers. Is the female autonomic nervous system cardioprotective?. Eur Heart J 1998, 19(9):1334-1341.
41. Stein P.K., Kleiger R.E., Rottman J.N. Differing effects of age on heart rate variability in men and women. Am J Cardiol 1997, 80:302-305.
42. Saleem S., Hussain M.M., Majeed S.M., Khan M.A. Gender differences of heart rate variability in healthy volunteers. J Pak Med Assoc 2012, 62:422-425.
43. Sookan T., McKune A.J. Heart rate variability in physically active individuals: reliability and gender characteristics. Cardiovasc J Afr 2012, 23(2):67-72.
44. Fairchild K.D., Srinivasan V., Moorman J.R., Gaykema R.P., Goehler L.E. Pathogen-induced heart rate changes associated with cholinergic nervous system activation. Am J Physiol Regul Integr Comp Physiol 2011, 300(2):330-339.
45. Thayer J.F., Ahs F., Fredrikson M., Sollers J.J., Wager T.D. A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev 2002, 36(2):747-756.
46. Dinas P.C., Koutedakis Y., Flouris A.D. Effects of active and passive tobacco cigarette smoking on heart rate variability. J Cardiol 2011, 163(2):109-115.
47. Schwarz A.M., Schächinger H., Adler R.H., Goetz S.M. Hopelessness is associated with decreased heart rate variability during championship chess games. Psychosom Med 2003, 65(4):658-661.
48. Greten F.R., Eckmann L., Greten T.F., Park J.M., Li Z.W., Egan L.J., et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118(3):285-296.